China CDC weekly · 2026
First Imported Case of Cerebral Schistosomiasis Mansoni - China, May 2025.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chen Weiqi, Zhang Yalan, Ma Xiaohui, Jiang Tiantian, Zhao Dongyang, Deng Yan
Аннотация
WHAT IS ALREADY KNOWN ABOUT THIS TOPIC?: Schistosoma mansoni (S. mansoni) is predominantly distributed across Africa, the Middle East, the Caribbean Islands, and South America, infecting approximately 54 million people annually. China is not an endemic region for schistosomiasis mansoni, and no cases of cerebral schistosomiasis mansoni have been previously documented.
WHAT IS ADDED BY THIS REPORT?: This report documents the first imported case of cerebral schistosomiasis mansoni in China. We present the epidemiological investigation, distinctive clinical manifestations, diagnostic challenges including misdiagnosis and delayed diagnosis, and the critical role of pathogen detection in case confirmation.
WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE?: With the continuous emergence of imported S. mansoni cases and the gradual expansion of intermediate host breeding grounds, active monitoring should be conducted for potential risks of local transmission within China. To prevent this disease from becoming endemic, CDCs and medical institutions must strengthen their diagnostic, treatment, and prevention capabilities, as well as their monitoring and early warning capacities for imported schistosomiasis mansoni.
WHAT IS ADDED BY THIS REPORT?: This report documents the first imported case of cerebral schistosomiasis mansoni in China. We present the epidemiological investigation, distinctive clinical manifestations, diagnostic challenges including misdiagnosis and delayed diagnosis, and the critical role of pathogen detection in case confirmation.
WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE?: With the continuous emergence of imported S. mansoni cases and the gradual expansion of intermediate host breeding grounds, active monitoring should be conducted for potential risks of local transmission within China. To prevent this disease from becoming endemic, CDCs and medical institutions must strengthen their diagnostic, treatment, and prevention capabilities, as well as their monitoring and early warning capacities for imported schistosomiasis mansoni.